Pinnacle Bancorp Inc. Purchases 157 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Pinnacle Bancorp Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.7% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 2,197 shares of the healthcare conglomerate’s stock after buying an additional 157 shares during the period. Pinnacle Bancorp Inc.’s holdings in UnitedHealth Group were worth $1,285,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of UNH. Bell Investment Advisors Inc boosted its holdings in UnitedHealth Group by 4.8% during the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 24 shares during the last quarter. Harbor Investment Advisory LLC lifted its holdings in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares in the last quarter. Austin Private Wealth LLC lifted its holdings in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares in the last quarter. Capital Insight Partners LLC lifted its holdings in shares of UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares in the last quarter. Finally, Collective Family Office LLC lifted its holdings in shares of UnitedHealth Group by 4.3% during the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after purchasing an additional 65 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 1.1 %

NYSE:UNH opened at $597.68 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market capitalization of $551.91 billion, a price-to-earnings ratio of 39.63, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The business has a fifty day moving average price of $582.98 and a 200-day moving average price of $529.56.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the business posted $6.14 EPS. UnitedHealth Group’s revenue for the quarter was up 6.4% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 55.70%.

Insider Activity

In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on UNH shares. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. Robert W. Baird boosted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. UBS Group boosted their price target on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Truist Financial boosted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $614.17.

View Our Latest Research Report on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).